Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer.
Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer. Oncotarget. 2015 Sep 15; 6(27):23548-60.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Ascites
Cell Line, Tumor
Cell Survival
Female
Gene Expression Regulation, Neoplastic
Glucose
Glycolysis
Humans
Hyperglycemia
Hypoglycemic Agents
Lactic Acid
MAP Kinase Signaling System
Metformin
Mice
Mice, Inbred C57BL
Ovarian Neoplasms
Pentose Phosphate Pathway
Phenformin
Proto-Oncogene Proteins c-myc
authors with profiles
Kathryn Mills
Abir Mukherjee
Ernst Robert Lengyel
Iris Romero